X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Pharma Contract Manufacturing 2025

Content Team by Content Team
7th December 2024
in Press Statements

The pharma contract manufacturing industry is projected to grow substantially, reaching $320 billion by 2029. This growth is linked to rising drug development costs, rapid technological advancements, and evolving regulatory rules.

In the fast-paced world of pharmaceuticals, effective partnerships between CMOs and pharmaceutical companies are crucial for swiftly producing life-saving drugs. As the global CMO market continues to grow, it’s imperative for pharmaceutical companies to strategically select and collaborate with the right partners to optimise operations, minimise costs, and drive innovation.

Pharma Contract Manufacturing 2025 will provide a platform for sharing best practice, building relationships and addressing common challenges collectively. From partner selection and cost management to digital transformation and sustainability, we will explore practical solutions and real-world case studies to help you build and sustain successful partnerships in today’s uncertain environment. Join us in Berlin at the Mercure Hotel from the 26-27th March 2025.

Hear from our 28 speakers who are leading roundtables, debates and collaborative discussions and network with our attendees as we tackle the current challenges facing the pharma industry.

The 2025 speaker lineup includes:

  • Ingrid Lux, Director, Quality Disposition Oncology and External Supply Small Molecule Europe, Takeda
  • Maik Talarczyk, Head, PMO ESO, Sandoz
  • Philip Coetzee, Director CMO Management, Daiichi Sankyo
  • Lucas Lucero Lopez, Associate Director, Vendor Management, AstraZeneca
  • Maria Palha, Associate Director, External Manufacturing Operations, UCB
  • Mohamed Fayez Monir, Head of Third Party Manufacturing, Boehringer Ingelheim

Key topics will include:

  • Embracing Sustainability: Exploring sustainable practices and reducing environmental impact.
  • Discussing Business Strategies: Particularly looking at pricing and contract negotiations.
  • Navigating Regulatory Changes: Understanding the implications of new regulations and developing compliance strategies.
  • Building Resilient Supply Chains: Mitigating risks and ensuring continuity of operations in a volatile environment.
  • Leveraging Digital Transformation: Harnessing technology to improve efficiency, quality, and innovation.

The full event agenda is available here for you to browse and use our code: PARTNER15 for 15% off your ticket.

Event venue: Mercure Hotel MOA Berlin , Stephanstraße 41 , 10559 Berlin, Germany

 

Previous Post

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Next Post

Women Leaders in Biopharma: The Way Forward

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Press Statements

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

11th December 2024
Next Post

Women Leaders in Biopharma: The Way Forward

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In